Purpose:
We sought to characterize adaptive changes to the revised United Network for Organ Sharing donor heart allocation policy and estimate long-term survival trends for heart transplant (HTx) recipients.
Methods:
Patients listed for HTx between October 17, 2013 and September 30, 2021 were identified from the United Network for Organ Sharing database, and stratified into pre- and postpolicy revision groups. Subanalyses were performed to examine trends in device utilization for extracorporeal membranous oxygenation (ECMO), durable left ventricular assist device (LVAD), intra-aortic balloon pump (IABP), microaxial support (Impella), and no mechanical circulatory support (non-MCS). Survival data post-HTx were fitted to parametric distributions and extrapolated to 5 years.
Results:
We identified 27,523 HTx waitlist candidates during the study period, most of whom (n = 16,376) were waitlisted in the prepolicy change period. Overall, 19,554 patients underwent HTx during the study period (pre: 12,037 and post: 7517). Listings increased after the policy change for ECMO (P < 0.01), Impella (P < 0.01), and IABP (P < 0.01) patients. Listings for LVAD (P < 0.01) and non-MCS (P < 0.01) patients decreased. HTx increased for ECMO (P < 0.01), Impella (P < 0.01), and IABP (P < 0.01) patients after the policy change and decreased for LVAD (P < 0.01) and non-MCS (P < 0.01) patients. Waitlist survival increased for the overall (P < 0.01), ECMO (P < 0.01), IABP (P < 0.01), and non-MCS (P < 0.01) groups. Waitlist survival did not differ for the LVAD (P = 0.8) and Impella (P = 0.1) groups. Post-transplant survival decreased for the overall (P < 0.01), LVAD (P < 0.01), and non-MCS (P < 0.01) populations.
Conclusions:
Allocation policy revisions have contributed to greater utilization of ECMO, Impella, and IABP, decreased utilization of LVADs and non-MCS, increased waitlist survival, and decreased post-HTx survival.